News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

November

14

TriSalus Life Sciences to Become Publicly Traded Through Merger with MedTech Acquisition Corporation

Oncology Therapeutics Company Focused on Transforming Cancer Treatment with Proprietary Innovative Therapies and Disruptive...

10

TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial

Studying the delivery of SD-101 via pressure-enabled drug delivery in adults with hepatocellular carcinoma...

20

TriSalus Life Sciences Announces Collaboration with the University of Colorado Anschutz Medical Campus

Three-year program aims to advance research on innovative immuno-oncology treatments for patients with liver...

6

TriSalus Life Sciences Appoints Sean Murphy to Board of Directors

Industry expert brings decades of experience commercializing biopharmaceutical, medical device and diagnostic products DENVER,...

14

TriSalus Life Sciences Presents Data at American Association of Cancer Research Showing Reduced Liver Tumor Burden from Toll-Receptor Agonists

Regional Delivery of Oligodeoxynucleotides (ODN2395) Showed Activation of Toll-Like Receptor Agonist in Mice Ineffective...

Recent developments